[Effect of mexidol on oxidative stress in cerebral variant of hypertensive crisis].
Parameters of oxidative stress were studied in 44 patients with grade II-III essential hypertension and cerebral variant of hypertensive crisis. All patients received antihypertensive treatment. Mexidol was administered intravenously (300 mg o.d.) for 7 days starting with the second day of a hypertensive crisis. Control group consisted of 27 patients who were not treated with mexidol. The level of lipid peroxidation products and parameters of antioxidative system were used for assessment of the state of oxidative stress. Significant increases of the coefficient of oxidative stress were registered at all study points in patients who were not treated with mexidol. Treatment with antioxidant mexidol was associated with decreased coefficient of oxidative stress throughout the whole study period (up to 14-th day).
Golikov
A P
AP
Golikov
P P
PP
Davydov
B V
BV
Riabinin
V A
VA
Luk'ianov
M M
MM
Kalinin
A N
AN
Klychnikova
E V
EV
Promanenkov
V K
VK
D000975:Antioxidants / Q000494:pharmacology* / Q000627:therapeutic use*; D001921:Brain / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress / Q000187:drug effects*; D010847:Picolines / Q000494:pharmacology* / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*
D000975:Antioxidants; D010847:Picolines; D010975:Platelet Aggregation Inhibitors; C070020:emoxypine succinate